Thermo Fisher Scientific reports Q3 2026 results and addresses performance on its earnings call, with market participants responding to the update via share-price movement. One outlet notes that while Thermo Fisher “tops” Q3 estimates, its shares slip after the earnings call, indicating that factors beyond the headline numbers may be weighing on investor sentiment.
A separate report covers Danaher’s Q3 2026 earnings, stating that it tops analysts’ estimates; however, Danaher shares fall in premarket trading. Across the coverage, the main common thread is the contrast between beating expectations and the immediate stock-market reaction, suggesting investors are reacting to details discussed during the calls (such as guidance, outlook, or other commentary) even when results exceed forecasts. The articles provide different emphases—one focuses on Danaher’s premarket decline, while another highlights Thermo Fisher’s slip—while both center on earnings-call transcripts and the ensuing market response.